| Product NDC: | 10019-177 |
| Proprietary Name: | Morphine Sulfate |
| Non Proprietary Name: | Morphine Sulfate |
| Active Ingredient(s): | 8 mg/mL & nbsp; Morphine Sulfate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10019-177 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20100526 |
| Package NDC: | 10019-177-44 |
| Package Description: | 25 VIAL in 1 BOX (10019-177-44) > 1 mL in 1 VIAL (10019-177-39) |
| NDC Code | 10019-177-44 |
| Proprietary Name | Morphine Sulfate |
| Package Description | 25 VIAL in 1 BOX (10019-177-44) > 1 mL in 1 VIAL (10019-177-39) |
| Product NDC | 10019-177 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Morphine Sulfate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20100526 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | MORPHINE SULFATE |
| Strength Number | 8 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |